As featured in Wegovy is the first-ever semaglutide FDA-approved specifically for chronic weight management the highest approved dose for weight loss, backed by the STEP clinical trials
Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for good PRINCETON, N.J., June 24, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications that mimic the action of naturally occurring GLP-1, an incretin hormone produced in the intestinal L-cells
Retatrutide sits at the leading edge of a research trajectory toward broader receptor coverage in metabolic peptides
Si sigue sin salir ni una gota tirar la pluma y utilizar una nueva